Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Herpecare is a topical gel developed by Procare Health for the management of genital herpes and other genital infections. The product is formulated with oxidized glycerol triesters (TGO), which act by forming a protective physical barrier over the affected skin and mucous membranes. This film-forming mechanism isolates the lesions from external irritants, helps alleviate symptoms such as pain, itching, and burning, and supports the natural healing and re-epithelialization process. Herpecare is typically classified as a Class IIa medical device in European markets and is indicated for use at the first sign of symptoms to reduce the duration and severity of outbreaks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Herpecare.